JPRN-UMIN000006048招募中未知
Interrelationship of Serum HER2-ECD with Pathological HER2 level (Human Epidermal Growth Factor Receptor Type2 - Extra Cellular Domain) in Operable Gastric Cancer Patients in Japan - sHER2-GC
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient with Breast cancer 2) Patient with active double cancer (synchronous double cancer and metachronous double cancer), excluding carcinoma in situ (lesions equal to intraepithelial or intramucosal cancer) judged to have been cured with local treatment. 3) Patient with severe complications, such as paralytic ileus, bowel obstruction, interstitial pneumonitis, pulmonary fibrosis, or uncontrollable diabetes mellitus, arrhythmias, heart failure, liver cirrhosis, and active hepatitis) 4) Exclude the patients who are recognized as inadequate patients by doctors with responsibility in this trial.
研究者
相似试验
已完成
不适用
Observational study of serum HER2 in HER2 positive advanced gastric cancer treated with trastuzumab in combination with capecitabine plus cisplatin(XP+H)Gastric cancerJPRN-UMIN000006445Sapporo Medical University 1st department of Internal Medicine10
招募中
Unknown
Exploring HER2 Overexpression and its Significance as a Biomarker in pathologic T-stage of de novo Muscle-Invasive Bladder CancerKCT0008808GangNeung Asan Hospital174
Unknown
不适用
HER2 Positive CTC in Advanced Gastric CancerHER2 Positive Advanced Gastric CancerNCT01847794Peking University50
已完成
不适用
Observational study of Serum HER2 in HER2 negative advanced gastric cancer treated with capecitabine plus cisplatin(XP)Gastric cancerJPRN-UMIN000006442Sapporo Medical University 1st department of Internal Medicine50
已完成
不适用
Correlation between Prognosis and HER2 status in Advanced/Recurrent Gastric Cancer: Multicenter Retrospective AnalysisAdvanced/Recurrent Gastric CancerJPRN-UMIN000006451ational Cancer Center Hospital East300